Rick Silva Email and Phone Number
Rick Silva work email
- Valid
- Valid
- Valid
Rick Silva personal email
- Valid
Rick Silva phone numbers
Biomedical research professional with expertise in large research collaborations, consortia, R&D alliances, IP asset portfolio management, medical product development partnerships, venture development, and seed funding. Over 20 years at the academic heath system-industry interface, with a record of operational excellence and closed deals. I specialize in new collaboration models and deal structures for scaling clinical data commons, biorepositories, novel tech development models (startup companies, academic enterprises, joint ventures), novel digital and genomic health product deployment models, & early stage capitalization of biomedical spinout companies.I angel invest and co-invest in syndicated and side-car opportunities for limited sectors Series B and later with serial entrepreneurs and serial fund managers: deep tech, AI, blockchain, medical informatics. I leverage 15 years of leadership experience in large academic biomedical commercialization enterprises to catalyze new pathways to clinical validation, commercialization, and market adoption of new tech emerging from "Big Biology" and "Big Medicine" datasets, a hallmark of the PRECISION MEDICINE paradigm. EXPERTISE: Data+ Database strategies for management dashboards & operational and clinical decision making (including use of SQL queries & SAS)+ Interrogation of large clinical, operational, docket management, & CRM data sets + Multi-omic data stewardship & clinical workflows in precision medicine (PGx and oncology)Management+ Team building+ Conflict resolution+ Operational metrics & dashboard developmentResearch+ Management and leadership in research, development, and clinical enterprises + Clinical trial partnerships & cohort discovery to aid accrual+ Clinical trial protocol development and regulatory science in oncology, pulmonary, and diabetes+ Clinical biomarker & diagnostic assay development+ DoD/VA medical collaboration modelsBusiness Development+ Collaboration & strategic alliance negotiation and management+ Technology licensing & development partnerships+ Early stage venture development & startup team building+ Intellectual property portfolio management+ Seed and A-round stage due diligence+ ...and unwinding when things don't pan out
Institute For Healthcare Access At Texas A&M University
View- Website:
- healthcare-access.tamu.edu
- Employees:
- 8
-
Faculty FellowInstitute For Healthcare Access At Texas A&M UniversityHouston, Tx, Us
-
Director Trec Clinicogenomic CoreTexas A&M University Mar 2023 - PresentCollege Station, Tx, UsLead implementation of a CPRIT funded clinicogenomics program for patients in a CPRIT funded cancer screening programs. The program is intended to identify validate biomarkers for cancer screening, understand the patient journey leading up to a cancer diagnosis, and incorporate genetic, environmental, socio-economic, and occupational factors driving cancer outcomes. -
Director Pharmacogenomics, Ibt Cpgm & Co-Founder Interprofessional Pharmacogenomics ClinicTexas A&M Health Science Center Sep 2021 - PresentBryan, Tx, UsThe Interprofessional Pharmacogenomic Clinic (IPGx) at Texas A&M is specialty clinical practice that informs medication management decisions for primary care practices and serves as a force multiplier that augments primary care capacity to improve outcomes for complex clinical cases and underserved populations in the Brazos Valley.A parallel research arm collects pharmacogenomic and clinical pharmacokinetic data through collaborations with CAP/CLIA diagnostic laboratories for use in quality improvement projects by TAMU faculty in collaboration with the private sector. The IPGx has a clinicogenomic registry developing best practices for longitudinal patient engagement and health economic outcomes research to inform PGx implementation and reimbursement. -
Executive Director Clinical | Translational | Industry Collaborations- Office Of Assoc Vp ResearchTexas A&M Health Science Center Sep 2019 - PresentBryan, Tx, UsCharged with expanding the portfolio of clinical, translational collaborations, grants, and processes enabling Texas A&M to be a partner of choice for clinical, translational, and industry projects leveraging the research infrastructure, clinical data commons, biorepositories, expertise, and patient populations available through Texas A&M's Health Sciences enterprises and affiliations.Signature programs*Pharmacogenomics clinic and research registry utilizing genotyping, pharmacokinetics, and artificial intelligence in the care of polypharmacy and chronic disease populations*Clinical stage energy delivery device for treatment of neurologic disease*Artificial intelligence drug discovery project to redesign and repurpose a clinical stage biopharmaceutical productInterested in the hard translational problems, like data linkage, disease prevention, natural products and commercialization Areas of active interest:-Prevention: Experimental cancer therapeutics and therapeutic agents with potential to prevent EMT in at risk populations. 1 active clinical stage industry collaboration.-Genomic medicine: Retrotransposon mediated disease processes (inflammation, fibrosis, EMT). Co-founded and leading an interprofessional initiative to deploy pharmacogenomic and artificial intelligence technology in a primary care medication management program (Interprofessional Pharmacogenomics Clinic). 3 active industry collaborations.-Natural products: Therapeutic potential of natural products containing eicosanoids and other lipid inflammatory mediators, PPARgamma ligands, specialized pro-resolution modulators, and omega-3 FA (my friends, yes, I know mechanism dont matter)-Clinical & translational research: Use of smart contracts, blockchain, and digital ledger technologies to enable compliant and low-friction clinical data and biospecimen transactions among translational research communities. 1 active industry collaboration, one active health care system collaboration.
-
Asst. Professor Translational Medical Sciences- Institute For Bioscience &Technology (Ibt@Tmc)Texas A&M Health Science Center Oct 2020 - PresentBryan, Tx, UsFaculty appointment in the Department of Translational Medical Sciences in the Institute for Bioscience and Technology, Texas A&M Houston Campus at the Texas Medical Center. Section Editor: Regulatory, Legal and Ethical Considerations in Precision Medicine, Comprehensive Precision Medicine (ELSEVIER) CommitteesBiotechnology Alliance at the Institute for Bioscience and Technology in HoustonClinical Trials and Diversity in Cancer (CPRIT)Scientific JSC- clinical stage interventional neurology project College of Dentistry in DallasHSC Clinical Research Data StrategyBiomarkers Task ForceGulf Coast Consortium Technology Commercialization REACHCo-founder and investigator: Interprofessional Pharmacogenomics Clinic and RegistryCourses taught: 2020 “Opportunity assessment and asset identification”. Special Topics in Starting a Biotechnology Company MSCI 689, Dr. Magnus Hook, Instructor2020 “Clinical trials and the Protocol as a commercial roadmap”. Special Topics in Starting a Biotechnology Company MSCI 689, Dr. Magnus Hook, Instructor2022 MSCI 689 "Special Topics: Foundations in Clinical and Regulatory Sciences", Instructor of Record2023 MSCI 689 Opportunity assessment and asset identification”. Special Topics in Biotechnology Instructor of Record
-
Co-FounderCadrx Precision Medicines Sep 2022 - PresentCADRx has harnessed the power of additive manufacturing (3D printing) to reformulate safter medications. CADRx reformulates drugs currently in human use into safer formulations for topical and preventative clinical indications. CADRx is initially focusing on developing its lead product: a new, noninvasive mucoadhesive patch (LeukoPlaxTM) designed to treat lesions in the mouth that are at risk of progressing to oral cancer.
-
Section Editor, Commercial, Regulatory, Legal Considerations, Comprehensive Precision MedicineElsevier May 2020 - Sep 2023Amsterdam, North Holland, NlDeveloping a set of chapters covering topics with an overarching theme of challenges and opportunities in integrating genomic, digital, and cellular therapies across the healthcare, academic, industry and government continuum in support of more informed clinical decision-making from the policy and regulator level down to the practitioner level. The work highlights changing incentives for investments in innovation, commercialization, and clinical validation of emerging technologies. -
Executive Director, Biomedical Corporate Alliances, Office Of The Senior Vice President Health Sci.The University Of Arizona Mar 2015 - Jul 2019Tucson, Arizona, UsOffice of Biomedical Corporate Allianceshttp://precisionhealth.ahsc.arizona.edu/biomedical-corporate-alliances I supported and coordinated most aspects of industry engagement as it relates to research collaborations, research consortia, data commons, and specimen interrogation collaborations for the AMC.I have developed novel collaboration models to leverage collaborative currencies (clinical cases, data, specimens, KOL knowledge) unique to academic medical centers and healthcare systems. Special emphasis to support cell therapy, precision medicine, and clinical -omics strategies of University of Arizona.Focused on partnerships in cell therapy, precision medicine, oncology, clinical trials, healthcare informatics, medical imaging. New enterprises created to address an internal operational need (particularly in medical informatics) are increasingly finding markets for their technology outside the walls of the institution. High profile examples abound: ARUP, Stentor's PACS system, Sinfonia Rx, Cerner (Multum), Explorys, Foundation Medicine, ClinImmune. External partnerships, technology access, and capabilities are increasingly important component of academic medical center's clinical, operational, and research strategies. I have worked at this health system-industry interface for 20+ years and developed deep case-based knowledge of the pathways and collaboration models for transfer of innovation across this interface , in both directions. Key role in the development of a diabetes cell therapy alliance: https://www.prnewswire.com/news-releases/procyon-technologies-llc-and-novo-nordisk-as-to-collaborate-on-the-development-of-a-stem-cell-based-therapy-for-type-1-diabetes-301188131.html -
Senior Director Commercialization (Tech Transfer) Uc Denver | Anschutz Medical CampusUniversity Of Colorado Sep 2012 - Mar 2015Responsibility for management of the commercialization and industry collaboration enterprise for the University of Colorado Denver (Anschutz Medical Campus, Downtown Denver Campus, and affiliate hospitals- Denver Health, Children's Hospital, and Affiliated VA faculty). Key activities of my organization include:= Facilitate collaborations to validate biomedical innovations, including clinical trials and health informatics= Manage a portfolio of over 150 active intellectual property licenses= Manage a pipeline of 125-135 inventions and 25-30 license transactions per year= >1 M P&L patent budget responsibilitySummary of accomplishments at University of Colorado 2002-2014- 58 startup companies created- $389 M in grant, seed, angel, and A round capital- $670 M in private and public equity investment- $2.6 B in aggregate equity investment and acquisition value- $50 M in research support for technology development- $68 M in licensing revenue- 277 licensing transactions with $48 M in guaranteed revenue- $12 M in technology development and validation investments (Proof of Concept)- 136 investments in medtech validation (POC) projects- 1250 invention disclosures - 1400 patents filed - 170 patents issued- $5 M in aggregate patent expenditures- Over 100 research collaborations and alliances- Over 6000 MTAs and CDAs- Mentored over 50 interns- Key role in a successful $40 M royalty monetization
-
Board DirectorColorado Institute For Drug, Device And Diagnostic Development Sep 2010 - Mar 2015My role was dual at CID4, as a Scientific Advisory Board member and a Board Director. CID4 actively managed the transition of medical discoveries into new ventures, invested in those ventures, and assisted those new ventures in securing grant and equity financing in support of technology validation. As of 2017....+ Investments in 9 companies+ 4 companies secured SBIR/STTR grants through collaborations with the University of Colorado+ 4 companies secured venture capital investment+ 6 products on the market+ 1 acquired at an up valuation
-
Director- Commercialization (Tech Transfer)University Of Colorado Jul 2007 - Sep 2012Denver, Colorado, UsIn this role I co-led of database redesign and development and expansion management dashboards, including optimization of SQL scripts to produce data summaries and dashboards for management decisions, patent portfolio decisions, CRM prioritization decisions, and in support of human resources decisions (merit based raises and promotions). I also was responsible for the management, training, mentorship and professional well-being of of 8-12 business development, contract management, and patent administration staff and interns. -
Assistant Director Commercializatrion (Tech Transfer)University Of Colorado Jul 2005 - Jun 2007Denver, Colorado, UsIn this role my key accomplishment was leading the development of optimized patent and contract docketing and workflows of our contract review and CRM systems and the planning of management dashboards and and automated workflows in our CRM system. Improved customer service and turn around time for external contract clients and improved visibility and reporting internal opportunity pipelines for inside business development users and also reporting of opportunity pipeline to middle management and executive leadership.Responsibility for the campus portfolio of patents (~100-200), licensing efforts (~12-30), marketing and business development (~100-150), and contract administration (~700/yr) for University of Colorado Anschutz Medical Campus (fka Health Sciences Center).
-
Interim DirectorFitzsimons Biobusiness Partners Jan 2007 - Sep 2008Lead a small venture development organization charged with providing a conduit of talent, seed stage capital, business advisors to nascent biomedical companies on the Front Range of Colorado.Business development strategiesCommercialization roadmapsAlliance development and managementPitch prepTeam building and executive recruitmentTechnology validation strategyPrograms and functions merged into CID4 in 2010
-
Licensing AssociateUniversity Of Colorado Denver Jul 2002 - Jul 2005Denver, Co, UsProfessional staff member charged with the management and business development of a portfolio of biomedical inventions from the University of Colorado's biomedical research enterprise and affiliated hospitals (Children's Hospital Colorado and Denver Health Hospital Authority)..
Rick Silva Skills
Rick Silva Education Details
-
Colorado State UniversityPhysiology -
University Of Colorado Boulder - Leeds School Of BusinessEntrepreneurship And Finance
-
New Mexico State UniversityAgriculture And Animal Science
Frequently Asked Questions about Rick Silva
What company does Rick Silva work for?
Rick Silva works for Institute For Healthcare Access At Texas A&m University
What is Rick Silva's role at the current company?
Rick Silva's current role is Faculty Fellow.
What is Rick Silva's email address?
Rick Silva's email address is rs****@****hsc.edu
What is Rick Silva's direct phone number?
Rick Silva's direct phone number is +194171*****
What schools did Rick Silva attend?
Rick Silva attended Colorado State University, University Of Colorado Boulder - Leeds School Of Business, New Mexico State University.
What are some of Rick Silva's interests?
Rick Silva has interest in Investing, Gardening, Traveling, Reading, Golf, Hunting, Fishing.
What skills is Rick Silva known for?
Rick Silva has skills like Technology Transfer, Start Ups, Life Sciences, Licensing, Biotechnology, Intellectual Property, Business Development, Leadership, Patents, Strategic Planning, Venture Capital, Business Strategy.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial